Clinical trial
Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in…
NCT00002839 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00002839 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx |
| Official title | PHASE II STUDY ON LARYNX PRESERVATION COMPARING INDUCTION CHEMOTHERAPY AND RADIOTHERAPY VERSUS ALTERNATING CHEMO-RADIOTHERAPY IN RESECTABLE HYPOPHARYNX AND LARYNX CANCERS |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin, fluorouracil, conventional surgery, neoadjuvant therapy, radiation therapy |
| Enrollment | 564 |
| Start date | Jul 1, 1996 |
| Primary completion | May 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 9, 2018 |
| Countries | Belgium, France, Israel, Italy, Netherlands, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: